These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27635109)

  • 1. Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling.
    Ziffels B; Ospel J; Grün K; Neri D; Pfeil A; Fritzenwanger M; Figulla HR; Jung C; Berndt A; Franz M
    Dis Markers; 2016; 2016():3695454. PubMed ID: 27635109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
    Franz M; Berndt A; Neri D; Galler K; Grün K; Porrmann C; Reinbothe F; Mall G; Schlattmann P; Renner A; Figulla HR; Jung C; Küthe F
    Int J Cardiol; 2013 Oct; 168(6):5344-51. PubMed ID: 23998545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of tenascin-C variants in congestive heart failure patients: comparative analysis of ischemic, dilated, and hypertensive cardiomyopathy.
    Franz M; Berndt A; Grün K; Kuethe F; Fritzenwanger M; Figulla HR; Jung C
    Clin Lab; 2014; 60(6):1007-13. PubMed ID: 25016707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of high sensitivity troponin T concentration in chronic stable patients with heart failure: Ischemic heart failure versus non-ischemic dilated cardiomyopathy.
    Bakal RB; Hatipoglu S; Kahveci G; Omaygenc MO; Unkun T; Akgun T; Sahin M; Elveran A; Ozveren O; Ozdemir N
    Cardiol J; 2014; 21(1):67-75. PubMed ID: 23799554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy.
    Terasaki F; Okamoto H; Onishi K; Sato A; Shimomura H; Tsukada B; Imanaka-Yoshida K; Hiroe M; Yoshida T; Kitaura Y; Kitabatake A;
    Circ J; 2007 Mar; 71(3):327-30. PubMed ID: 17322629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy.
    Nakamura T; Funayama H; Kubo N; Yasu T; Kawakami M; Momomura S; Ishikawa SE
    Int J Cardiol; 2009 Jan; 131(2):186-91. PubMed ID: 18192038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy.
    Wojciechowska C; Romuk E; Tomasik A; Skrzep-Poloczek B; Nowalany-Kozielska E; Birkner E; Jacheć W
    Mediators Inflamm; 2014; 2014():147040. PubMed ID: 25400332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy.
    Wu T; Chen Y; Du Y; Tao J; Zhou Z; Yang Z
    Cell Physiol Biochem; 2018; 46(5):1939-1950. PubMed ID: 29719295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A
    Bäz L; Roßberg M; Grün K; Kretzschmar D; Berndt A; Schulze PC; Jung C; Franz M
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34207881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure.
    McConnell PI; del Rio CL; Jacoby DB; Pavlicova M; Kwiatkowski P; Zawadzka A; Dinsmore JH; Astra L; Wisel S; Michler RE
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1001. PubMed ID: 16214511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure biomarkers in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
    Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A; Bloch W; Antonyan A; Goebel H; Fries JU; Schlensak C; Beyersdorf F; Geissler HJ
    Lymphology; 2010 Sep; 43(3):110-7. PubMed ID: 21226413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure.
    Cappuzzello C; Di Vito L; Melchionna R; Melillo G; Silvestri L; Cesareo E; Crea F; Liuzzo G; Facchiano A; Capogrossi MC; Napolitano M
    J Transl Med; 2011 Mar; 9():28. PubMed ID: 21418620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.
    Kissel CK; Lehmann R; Assmus B; Aicher A; Honold J; Fischer-Rasokat U; Heeschen C; Spyridopoulos I; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2007 Jun; 49(24):2341-9. PubMed ID: 17572250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
    Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
    BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy.
    Doesch C; Streitner F; Bellm S; Suselbeck T; Haghi D; Heggemann F; Schoenberg SO; Michaely H; Borggrefe M; Papavassiliu T
    Obesity (Silver Spring); 2013 Mar; 21(3):E253-61. PubMed ID: 23592680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure.
    Taléns-Visconti R; Rivera Otero M; Sancho-Tello MJ; de Burgos FG; Martínez-Dolz L; Sevilla B; Climent V; Cortés R; Salvador A; Sogorb F; Miro V; Valero R; Perez-Boscá JL; Bertomeu V; Portolés M; Payá R
    Eur J Echocardiogr; 2006 Jan; 7(1):45-52. PubMed ID: 15939671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.